137 related articles for article (PubMed ID: 17766321)
21. Dangers of non-sedating antihistamines.
Himmel MH; Honig PK; Worobec AS
Lancet; 1997 Jul; 350(9070):69; author reply 69-70. PubMed ID: 9217741
[No Abstract] [Full Text] [Related]
22. Movement disorders induced by gastrointestinal drugs: two paediatric cases.
Elzinga-Huttenga J; Hekster Y; Bijl A; Rotteveel J
Neuropediatrics; 2006 Apr; 37(2):102-6. PubMed ID: 16773510
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
[TBL] [Abstract][Full Text] [Related]
24. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
25. [The arrhythmogenic potentials of cisapride].
Telò D
G Ital Cardiol; 1998 Dec; 28(12):1458. PubMed ID: 9887403
[No Abstract] [Full Text] [Related]
26. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
Craig-McFeely PM; Freemantle SL; Pearce GL; Shakir SA
Br J Gen Pract; 2000 Feb; 50(451):148. PubMed ID: 10750216
[No Abstract] [Full Text] [Related]
27. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
28. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
Tremlett HL; Oger J
Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392
[TBL] [Abstract][Full Text] [Related]
29. Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.
Carleton B; Poole R; Smith M; Leeder J; Ghannadan R; Ross C; Phillips M; Hayden M
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):713-21. PubMed ID: 19507171
[TBL] [Abstract][Full Text] [Related]
30. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
31. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
Okezie EO; Olufunmilayo F
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
[TBL] [Abstract][Full Text] [Related]
32. Severe cardiac arrhythmia on fexofenadine?
Prescrire Int; 2000 Feb; 9(45):212. PubMed ID: 11503802
[TBL] [Abstract][Full Text] [Related]
33. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
[TBL] [Abstract][Full Text] [Related]
34. Cisapride and ventricular arrhythmia.
Hennessy S; Leonard CE; Newcomb C; Kimmel SE; Bilker WB
Br J Clin Pharmacol; 2008 Sep; 66(3):375-85. PubMed ID: 18662288
[TBL] [Abstract][Full Text] [Related]
35. Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems?
De Bruin ML; van Puijenbroek EP; Egberts AC; Hoes AW; Leufkens HG
Br J Clin Pharmacol; 2002 Apr; 53(4):370-4. PubMed ID: 11966667
[TBL] [Abstract][Full Text] [Related]
36. Cisapride controversy.
Sharma MP
Trop Gastroenterol; 2002; 23(4):188-9. PubMed ID: 12833708
[No Abstract] [Full Text] [Related]
37. Preclinical assessment of drug-induced proarrhythmias: role of the arterially perfused rabbit left ventricular wedge preparation.
Wang D; Patel C; Cui C; Yan GX
Pharmacol Ther; 2008 Aug; 119(2):141-51. PubMed ID: 18423604
[TBL] [Abstract][Full Text] [Related]
38. Severe cardiac arrythmia on cisapride.
Prescrire Int; 2000 Oct; 9(49):144-5. PubMed ID: 11603415
[TBL] [Abstract][Full Text] [Related]
39. Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review.
Garnett CE; Beasley N; Bhattaram VA; Jadhav PR; Madabushi R; Stockbridge N; Tornøe CW; Wang Y; Zhu H; Gobburu JV
J Clin Pharmacol; 2008 Jan; 48(1):13-8. PubMed ID: 18094216
[TBL] [Abstract][Full Text] [Related]
40. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
